Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
- 19 March 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (7), 4586-4591
- https://doi.org/10.1073/pnas.072647999
Abstract
Calcineurin is a calcium-calmodulin-regulated, serine-threonine phosphatase that functions as a key inducer of stress responsive gene expression in multiple cell types through a direct activation of nuclear factor of activated T cells and myocyte enhancer factor 2 transcription factors. In cardiomyocytes, calcineurin signaling has been implicated in the regulation of the hypertrophic response caused by pressure overload or neuroendocrine stimulation. Three separate genes encode the catalytic subunit of calcineurin in mammalian cells, CnAalpha, CnAbeta, and CnAgamma. To evaluate the necessary function of calcineurin as a hypertrophic regulatory factor, the CnAbeta gene was disrupted in the mouse. CnAbeta-deficient mice were viable, fertile, and overtly normal well into adulthood, but displayed a 80% decrease in calcineurin enzymatic activity in the heart that was associated with a 12% reduction in basal heart size. CnAbeta-deficient mice were dramatically impaired in their ability to mount a productive hypertrophic response induced by pressure overload, angiotensin II infusion, or isoproterenol infusion. Analysis of marker genes associated with the hypertrophic response revealed a partial defect in the molecular program of hypertrophy. Collectively, these data solidify the hypothesis that calcineurin functions as a central regulator of the cardiac hypertrophic growth response in vivo.Keywords
This publication has 31 references indexed in Scilit:
- Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart FailureCirculation, 2001
- The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic miceThe EMBO Journal, 2000
- An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathyJournal of Clinical Investigation, 2000
- Calcineurin Blockade Prevents Cardiac Mitogen-activated Protein Kinase Activation and Hypertrophy in Renovascular HypertensionJournal of Biological Chemistry, 2000
- Calcineurin Inhibitor Attenuates Left Ventricular Hypertrophy, Leading to Prevention of Heart Failure in Hypertensive RatsCirculation, 2000
- Calcineurin and BeyondCirculation Research, 2000
- Many Pathways to Cardiac HypertrophyJournal of Molecular and Cellular Cardiology, 2000
- Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload HypertrophyCirculation, 2000
- Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the HeartJournal of Biological Chemistry, 2000
- Calcineurin: Form and FunctionPhysiological Reviews, 2000